Alpha Tau Medical (DRTS) Operating Leases (2022 - 2026)

Alpha Tau Medical has disclosed Operating Leases across 5 years of filings, most recently posting $6.7 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $6.7 million, up 15.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 million (up 15.76% YoY), and the FY2025 annual result was $6.2 million, up 4.68% from the prior year.
• Operating Leases came in at $6.7 million for Q1 2026 at Alpha Tau Medical, up from $6.2 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $6.7 million in Q1 2026 to a low of $4.5 million in Q4 2022.
• The 5-year median for Operating Leases is $6.1 million (2024), against an average of $5.9 million.
• Across the five-year window, Operating Leases jumped 45.98% in 2023 and dropped 9.69% in 2024, its largest moves.
• Alpha Tau Medical's Operating Leases stood at $4.5 million in 2022, then soared by 45.98% to $6.6 million in 2023, then decreased by 9.69% to $6.0 million in 2024, then climbed by 4.68% to $6.2 million in 2025, then increased by 7.91% to $6.7 million in 2026.
• The last three Operating Leases figures came in at $6.7 million (Q1 2026), $6.2 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.